8-K: Leidos Holdings Exceeds Expectations in Q1 2024, Raises Full-Year Guidance

Leidos reported a strong first quarter for fiscal year 2024, with revenue up 7% year-over-year and significant increases in net income and adjusted EBITDA, leading to raised full-year guidance.

Summary

• Leidos Holdings, Inc. announced its financial results for the first quarter of fiscal year 2024, which ended on March 29, 2024.
• The company reported revenues of $3.98 billion, a 7% increase compared to the same quarter last year.
• Net income for the quarter was $283 million, or $2.07 per diluted share, representing a 73% and 77% year-over-year increase, respectively.
• Adjusted EBITDA reached $490 million, a 42% increase year-over-year, with a record margin of 12.3%.
• Non-GAAP diluted earnings per share were $2.29, up 56% year-over-year.
• Cash flow from operations was $63 million, and free cash flow was $46 million.
• Net bookings for the quarter totaled $3.7 billion, resulting in a book-to-bill ratio of 0.9 for the quarter and 1.1 for the trailing twelve months.
• Leidos has updated its fiscal year 2024 guidance, raising revenue expectations to $16.0 $16.4 billion, adjusted EBITDA margin to mid-to-high 11%, non-GAAP diluted EPS to $8.40 $8.80, and operating cash flow to approximately $1.3 billion.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong financial results, increased guidance, and positive management commentary. The company is clearly performing well and is optimistic about the future.

Positives

• The company experienced strong revenue growth across all customer segments, particularly in managed health services.
• Profitability significantly improved due to increased volumes on fixed-rate managed health services and better cost control.
• Leidos demonstrated strong cash flow generation and returned significant capital to shareholders.
• The company's backlog remains robust, providing a solid foundation for future revenue.
• The raised full-year guidance indicates management's confidence in continued strong performance.
• The company's book-to-bill ratio for the trailing twelve months is a healthy 1.1.

Negatives

• The book-to-bill ratio for the quarter was 0.9, indicating that new bookings did not fully replace the revenue recognized during the quarter.
• Defense Systems segment operating income margin decreased due to program mix shifts.

Risks

• The company's performance is subject to developments in U.S. government defense and non-defense budgets, including potential budget reductions and delays.
• Uncertainties in tax due to new tax legislation or other regulatory developments could impact financial results.
• Rising inflationary pressures and fluctuations in interest rates may affect costs and profitability.
• Delays in the U.S. government contract procurement process or the award of contracts could impact revenue.
• The company faces risks related to cybersecurity, data security, and other security threats.
• The company's ability to attract and retain skilled employees is crucial for its success.
• The company's ability to accurately estimate costs on fixed-price contracts is important for profitability.

Future Outlook

Leidos has raised its full-year fiscal 2024 guidance, expecting revenues between $16.0 and $16.4 billion, adjusted EBITDA margin in the mid-to-high 11% range, non-GAAP diluted EPS between $8.40 and $8.80, and approximately $1.3 billion in operating cash flow.

Management Comments

• Thomas Bell, Leidos Chief Executive Officer, stated that the strong start to the year demonstrates the team's ability to deliver for its employees, customers, and shareholders.
• He also mentioned that with greater visibility around customer funding and performance ahead of plan, they are raising guidance on all metrics ahead of their typical pace.
• Bell emphasized that 2024 will showcase their commitment to profitable growth.
• He noted that their focus remains on operational execution while developing a robust strategy, investing in disruptive technology-driven solutions, and unlocking maximum value through their capability-based organization.

Industry Context

Leidos' strong performance reflects the continued demand for technology and services in the government and health sectors. The company's focus on innovation and operational execution positions it well to capitalize on these trends. The increased guidance suggests confidence in the company's ability to maintain its growth trajectory in a competitive market.

Comparison to Industry Standards

• Leidos' 7% revenue growth is solid compared to other large government contractors, many of whom are seeing mid-single-digit growth.
• The 42% increase in adjusted EBITDA and the 12.3% margin are particularly impressive, suggesting strong operational efficiency and cost control compared to peers like General Dynamics and Lockheed Martin.
• The 77% increase in diluted EPS significantly outperforms many of its competitors, indicating strong profitability.
• The book-to-bill ratio of 0.9 for the quarter is slightly below 1, which is a common benchmark for maintaining backlog, but the trailing twelve-month ratio of 1.1 is healthy.
• The raised guidance across all metrics is a positive sign, indicating that Leidos is outperforming its initial expectations and is confident in its future performance, which is not always the case with other companies in the sector.

Stakeholder Impact

• Shareholders will benefit from the strong financial performance, increased guidance, and return of capital through share repurchases and dividends.
• Employees will benefit from the company's success and commitment to growth.
• Customers will benefit from the company's focus on delivering innovative solutions.
• Suppliers and creditors will benefit from the company's strong financial position.

Next Steps

• Leidos management will discuss operations and financial results in an earnings conference call on April 30, 2024.
• The company will continue to focus on operational execution, developing a robust strategy, investing in disruptive technology-driven solutions, and unlocking maximum value through its capability-based organization.

Key Dates

Keywords

Leidos, Financial Results, Earnings, Revenue, EBITDA, EPS, Bookings, Backlog, Guidance, Defense, Health, Technology, Government Contracts